Skip to main content
Top
Published in: Annals of Nuclear Medicine 2/2020

01-02-2020 | Computed Tomography | Original Article

Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study

Authors: Yoko Satoh, Utaroh Motosugi, Masamichi Imai, Hiroshi Onishi

Published in: Annals of Nuclear Medicine | Issue 2/2020

Login to get access

Abstract

Objective

High-resolution dedicated breast positron emission tomography (dbPET) can visualize breast cancer more clearly than whole-body PET/computed tomography (CT). In Japan, the combined use of dbPET and whole-body PET/CT is necessary in indications for health insurance. Although several clinical studies have compared both devices, a physical evaluation by the phantom test has not been reported. The aim of this study was to compare the ability of ring-shaped dbPET and whole-body PET/CT using a common phantom with reference to the Japanese guideline for the oncology 18F-fluorodeoxyglucose (FDG)-PET/CT data acquisition protocol.

Methods

A cylindrical breast phantom with four spheres of different diameters (16, 10, 7.5, and 5 mm) filled an FDG solution at sphere-to-background radioactivity ratios (SBRs) of 2:1, 4:1, and 8:1 was prepared. Images were then acquired by whole-body PET/CT and subsequently by dbPET. The reconstructed images were visually evaluated and the coefficient of variation and uniformity of the background (CVbackground and SDΔSUVmean), percentages of contrast and background variability (%QH,5mm and %N5mm), and their ratio (%QH,5mm/N5mm), and relative recovery coefficient were compared with the standards defined in the protocol for whole-body PET/CT.

Results

The parameters were calculated at an SBR of 8:1, which was the only SBR in which a 5-mm sphere was visible on both devices. The standards were defined as < 10% for CVbackground, ≤ 0.025 for SDΔSUVmean, < 5.6% for %N5mm, > 2.8 for %QH,5mm/N5mm, and > 0.38 for the relative recovery coefficient of the smallest sphere (10 mm in diameter) in the protocol for whole-body PET/CT (the %QH,5mm was not determined for that protocol); the respective values were 6.14%, 0.024, 4.55%, 3.66, and 0.33 for dbPET and 2.21%, 0.021, 3.11%, 1.72, and 0.18 for PET/CT. The QH,5mm was 16.67% for dbPET and 5.34% for PET/CT. The human images also showed higher lesion-to-background contrast on dbPET than on PET/CT despite the noisier background observed with dbPET.

Conclusion

The common phantom study showed that the background was noisier and that the contrast was much higher in the dbPET image than in the PET/CT image. The acquisition protocol and standards for dbPET will need to be different from those used for whole-body PET/CT.
Literature
1.
go back to reference Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 2013;266:388–405.CrossRef Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 2013;266:388–405.CrossRef
2.
go back to reference Lee SM, Bae SK, Kim TH, Yoon HK, Jung SJ, Park JS, et al. Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy. Clin Nucl Med. 2014;39:882–6.CrossRef Lee SM, Bae SK, Kim TH, Yoon HK, Jung SJ, Park JS, et al. Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy. Clin Nucl Med. 2014;39:882–6.CrossRef
3.
go back to reference Satoh Y, Nambu A, Ichikawa T, Onishi H. Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. BMC Cancer. 2014;14:525.CrossRef Satoh Y, Nambu A, Ichikawa T, Onishi H. Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. BMC Cancer. 2014;14:525.CrossRef
4.
go back to reference Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumor stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901.CrossRef Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumor stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901.CrossRef
5.
go back to reference Ichizawa N, Fukutomi T, Iwamoto E, Akashi-Tanaka S. Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification. Jpn J Clin Oncol. 2002;32:108–9.CrossRef Ichizawa N, Fukutomi T, Iwamoto E, Akashi-Tanaka S. Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification. Jpn J Clin Oncol. 2002;32:108–9.CrossRef
6.
go back to reference Kumar R, Chauhan A, Zhuang H, Chandra P, Achnall M, Alvavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 2006;98:267–74.CrossRef Kumar R, Chauhan A, Zhuang H, Chandra P, Achnall M, Alvavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 2006;98:267–74.CrossRef
7.
go back to reference Bowen SL, Wu Y, Chaudhari AJ, Fu L, Packard NJ, Burkett GW, et al. Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med. 2009;50:1401–8.CrossRef Bowen SL, Wu Y, Chaudhari AJ, Fu L, Packard NJ, Burkett GW, et al. Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med. 2009;50:1401–8.CrossRef
8.
go back to reference Fowler AM. A molecular approach to breast imaging. J Nucl Med. 2014;55:177–80.CrossRef Fowler AM. A molecular approach to breast imaging. J Nucl Med. 2014;55:177–80.CrossRef
9.
go back to reference Kalinyak JE, Berg WA, Schilling K, Madsen KS, Narayanan D, Tartar M. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:260–75.CrossRef Kalinyak JE, Berg WA, Schilling K, Madsen KS, Narayanan D, Tartar M. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:260–75.CrossRef
10.
go back to reference Yamamoto Y, Ozawa Y, Kubouchi K, Nakamura S, Nakajima Y, Inoue T. Comparative analysis of sensitivity of positron emission mammography and whole-body PET in relation to tumor size. Clin Nucl Med. 2015;40:21–5.CrossRef Yamamoto Y, Ozawa Y, Kubouchi K, Nakamura S, Nakajima Y, Inoue T. Comparative analysis of sensitivity of positron emission mammography and whole-body PET in relation to tumor size. Clin Nucl Med. 2015;40:21–5.CrossRef
11.
go back to reference Nishimatsu K, Nakamoto Y, Miyake KK, Ishimori T, Kanao S, Toi M, et al. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT. Eur J Radiol. 2017;90:138–45.CrossRef Nishimatsu K, Nakamoto Y, Miyake KK, Ishimori T, Kanao S, Toi M, et al. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT. Eur J Radiol. 2017;90:138–45.CrossRef
12.
go back to reference Nakamoto R, Nakamoto Y, Ishimori T, Nishimatsu K, Miyake KK, Kanao S, et al. Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors. Nucl Med Commun. 2017;38:388–95.CrossRef Nakamoto R, Nakamoto Y, Ishimori T, Nishimatsu K, Miyake KK, Kanao S, et al. Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors. Nucl Med Commun. 2017;38:388–95.CrossRef
13.
go back to reference Hosono M, Saga T, Ito K, Kumita S, Sasaki M, Senda M, et al. Clinical practice guideline for dedicated breast PET. Ann Nucl Med. 2014;28:597–602.CrossRef Hosono M, Saga T, Ito K, Kumita S, Sasaki M, Senda M, et al. Clinical practice guideline for dedicated breast PET. Ann Nucl Med. 2014;28:597–602.CrossRef
14.
go back to reference Miyake KK, Matsumoto K, Inoue M, Nakamoto Y, Kanao S, Oishi T, et al. Performance evaluation of a new dedicated breast PET scanner using NEMA NU4-2008 standards. J Nucl Med. 2014;55:1198–203.CrossRef Miyake KK, Matsumoto K, Inoue M, Nakamoto Y, Kanao S, Oishi T, et al. Performance evaluation of a new dedicated breast PET scanner using NEMA NU4-2008 standards. J Nucl Med. 2014;55:1198–203.CrossRef
15.
go back to reference Mitsumoto T, Uno K, Irie M, Wu J, Sasamori H, Tsuchiya Y, et al. The potential of dedicated breast PET with a ring-type scanner—basic evaluation and clinical experience. Radioisotopes. 2018;67:309–19.CrossRef Mitsumoto T, Uno K, Irie M, Wu J, Sasamori H, Tsuchiya Y, et al. The potential of dedicated breast PET with a ring-type scanner—basic evaluation and clinical experience. Radioisotopes. 2018;67:309–19.CrossRef
16.
go back to reference Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0. Ann Nucl Med. 2014;28:693–705.CrossRef Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0. Ann Nucl Med. 2014;28:693–705.CrossRef
17.
go back to reference MacDonald L, Edwards J, Lewellen T, Rogers J, Kinahan P. Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II. IEEE Nucl Symp Conf Rec. 2008;11:4494–501. MacDonald L, Edwards J, Lewellen T, Rogers J, Kinahan P. Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II. IEEE Nucl Symp Conf Rec. 2008;11:4494–501.
18.
go back to reference Raylman RR, Abraham J, Hazard H, Koren C, Filburn S, Schreiman JS, et al. Initial clinical test of a breast PET scanner. J Med Imaging Radiat Oncol. 2011;55:58–64.CrossRef Raylman RR, Abraham J, Hazard H, Koren C, Filburn S, Schreiman JS, et al. Initial clinical test of a breast PET scanner. J Med Imaging Radiat Oncol. 2011;55:58–64.CrossRef
19.
go back to reference Qi J, Kuo C, Huesman RH, Klein GJ, Moses WW, Reutter BW. Comparison of rectangular and dual-planar positron emission mammography scanners. IEEE Trans Nucl Sci. 2002;49:2089–96.CrossRef Qi J, Kuo C, Huesman RH, Klein GJ, Moses WW, Reutter BW. Comparison of rectangular and dual-planar positron emission mammography scanners. IEEE Trans Nucl Sci. 2002;49:2089–96.CrossRef
20.
go back to reference Yamakawa Y, Kitamura K. Attenuation correction using level set method for application specific PET scanners. In: Nuclear science symposium and medical imaging conference (NSS/MIC) IEE. pp 3130–2; 2011. Yamakawa Y, Kitamura K. Attenuation correction using level set method for application specific PET scanners. In: Nuclear science symposium and medical imaging conference (NSS/MIC) IEE. pp 3130–2; 2011.
21.
go back to reference Bailey DL, Meikle SR. A convolution-subtraction scatter correction method for 3D PET. Phys Med Biol. 1994;39:411–24.CrossRef Bailey DL, Meikle SR. A convolution-subtraction scatter correction method for 3D PET. Phys Med Biol. 1994;39:411–24.CrossRef
22.
go back to reference Park HH, Shin JY, Lee JY, Jin GH, Kim HS, Lyu KY, et al. Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:2469–72.PubMed Park HH, Shin JY, Lee JY, Jin GH, Kim HS, Lyu KY, et al. Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:2469–72.PubMed
23.
go back to reference Leithner D, Baltzer PA, Magometschnigg HF, et al. Quantitative assessment of breast parenchymal uptake on 18F-FDG PET/CT: correlation with age, background parenchymal enhancement, and amount of fibroglandular tissue on MRI. J Nucl Med. 2016;57:1518–22.CrossRef Leithner D, Baltzer PA, Magometschnigg HF, et al. Quantitative assessment of breast parenchymal uptake on 18F-FDG PET/CT: correlation with age, background parenchymal enhancement, and amount of fibroglandular tissue on MRI. J Nucl Med. 2016;57:1518–22.CrossRef
24.
go back to reference Satoh Y, Motosugi U, Omiya Y, Onishi H. Unexpected abnormal uptake in the breasts at dedicated breast PET: incidentally detected small cancers or nonmalignant features? AJR Am J Roentgenol. 2019;212:443–9.CrossRef Satoh Y, Motosugi U, Omiya Y, Onishi H. Unexpected abnormal uptake in the breasts at dedicated breast PET: incidentally detected small cancers or nonmalignant features? AJR Am J Roentgenol. 2019;212:443–9.CrossRef
25.
go back to reference Phantom test procedure for whole body PET imaging using 18F–FDG, 3rd ed. Japanese Society of Nuclear Medicine, PET Nuclear Medicine Committee; 2017. Phantom test procedure for whole body PET imaging using 18F–FDG, 3rd ed. Japanese Society of Nuclear Medicine, PET Nuclear Medicine Committee; 2017.
26.
go back to reference Yamamoto Y, Tasaki Y, Kuwada Y, Ozawa Y, Inoue T. A preliminary report of breast cancer screening by positron emission mammography. Ann Nucl Med. 2016;30:130–7.CrossRef Yamamoto Y, Tasaki Y, Kuwada Y, Ozawa Y, Inoue T. A preliminary report of breast cancer screening by positron emission mammography. Ann Nucl Med. 2016;30:130–7.CrossRef
27.
go back to reference García Hernández T, Vicedo González A, Ferrer Rebolleda J, Sánchez Jurado R, Roselló Ferrando J, Brualla González L, et al. Performance evaluation of a high resolution dedicated breast PET scanner. Med Phys. 2016;43:2261–72.CrossRef García Hernández T, Vicedo González A, Ferrer Rebolleda J, Sánchez Jurado R, Roselló Ferrando J, Brualla González L, et al. Performance evaluation of a high resolution dedicated breast PET scanner. Med Phys. 2016;43:2261–72.CrossRef
28.
go back to reference Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging. 2013;40:1507–15.CrossRef Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging. 2013;40:1507–15.CrossRef
Metadata
Title
Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study
Authors
Yoko Satoh
Utaroh Motosugi
Masamichi Imai
Hiroshi Onishi
Publication date
01-02-2020
Publisher
Springer Singapore
Published in
Annals of Nuclear Medicine / Issue 2/2020
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-019-01422-0

Other articles of this Issue 2/2020

Annals of Nuclear Medicine 2/2020 Go to the issue

Acknowledgment to Reviewers

Acknowledgment to Reviewers